Resources Archive

Filter:

Read more

January 2022

Publication: Financial Times

AI harnessed for early identification of cardiovascular problems

Cardiovascular disease is the world’s biggest killer, responsible for almost 18m deaths a year, according to the World Health Organization….

Read more

January 2022

Publication: Cardiovascular Research, Volume 118, Issue 2

ESC CVD Prevention Guidelines 2021: Improvements, Controversies, and Opportunities

The third iteration of the European Society of Cardiology (ESC) cardiovascular disease (CVD) prevention guidelines was recently released at the…

Read more

January 2022

Publication: Heart 2022;108:1510-15

Cardiovascular computed tomography imaging for coronary artery disease risk: plaque, flow and fat

CCTA has emerged as the preferred non-invasive modality for the study of chest pain due to possible underlying CAD, and…

Read more

December 2021

Publication: British Heart Foundation (BHF)

British Heart Foundation: Our research highlights of 2021

From AI technology that can predict heart attacks to a potential new drug for incurable vascular dementia, the BHF has…

Read more

December 2021

Publication: WIRED

WIRED: The Hottest Startups in Oxford

Oxford is already home to one of the world’s most prestigious universities. Now its startup scene is finally getting the…

Read more

December 2021

Publication: Industrial News UK

AI to improve evaluation of diabetes using routine CT

We’ve been featured as the cover story in Industrial News magazine. Read the full article here.

Read more

October 2021

Publication: Physicians' Academy for Cardiovascular Education

Novel insights in inflammatory makers, AI, diagnostic tools and prediction of CV risk

This series consists of three educational videos. In the first lecture, Peter Libby discusses the role of inflammation in atherosclerosis….

Read more

October 2021

Publication: DiCardiology.com

CT Coronary Perivascular fat assessment can stratify cardiac risk associated with high-risk plaques.

October 6, 2021 — Data presented during the late-breaking science session at the European Society of Cardiology (ESC) 2021 Congress showed the…
  • Registered in England and Wales under company number 11429590
  • CaRi-Heart® is limited to investigational use in the United States.

All contents of this website are copyright 2018 - 2021 Caristo Diagnostics Ltd. All rights reserved. No content may be copied or reproduced without the express permission of Caristo Diagnostics Ltd.
All copyright, trade-marks, design rights, database rights, patents and other intellectual property rights (registered and unregistered) in and on this website are owned by Caristo Diagnostics Ltd. and/or certain third parties.